<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 16.7: Pharmacology and Substance Use Navigation | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box p {
 margin: 0;
 font-size: 15px;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: linear-gradient(135deg, #faf5ff, #f3e8ff);
 border: 1px solid #e9d5ff;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.question-item {
 background: white;
 padding: 24px;
 border-radius: 12px;
 margin-bottom: 16px;
 border: 1px solid #e9d5ff;
}

.question-item:last-child {
 margin-bottom: 0;
}

.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}

.question-number {
 background: #a855f7;
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}

.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}

.reveal-btn {
 background: white;
 border: 2px solid #d8b4fe;
 color: #7e22ce;
 padding: 10px 20px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 cursor: pointer;
 transition: all 0.2s;
 margin-top: 12px;
}

.reveal-btn:hover {
 background: #7e22ce;
 color: white;
 border-color: #7e22ce;
}

.answer-text {
 display: none;
 margin-top: 16px;
 padding-top: 16px;
 border-top: 1px solid #e9d5ff;
 color: #4b5563;
 font-size: 15px;
 line-height: 1.6;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.takeaways-box .box-label {
 color: #166534;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}

.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #166534;
 border-bottom: 1px solid rgba(34, 197, 94, 0.2);
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #22c55e;
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}
.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}
.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}
.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 16: L2: Advanced Case Studies</span>
 <h1 class="lesson-title">Pharmacology and Substance Use Navigation</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 14 min read</span>
 <span class="meta-badge"><span class="icon">üìö</span> Lesson 7 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute</div>
 <div class="title">Certified Breastfeeding Support Coach‚Ñ¢</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#medication-screening"><span class="section-num">01</span>Evidence-Based Medication Screening</a></li>
 <li><a href="#high-risk-medications"><span class="section-num">02</span>Troubleshooting High-Risk Medications</a></li>
 <li><a href="#maternal-anxiety"><span class="section-num">03</span>Reducing Maternal Anxiety</a></li>
 <li><a href="#chemotherapy-case"><span class="section-num">04</span>Case Study: Chemotherapy</a></li>
 <li><a href="#substance-use"><span class="section-num">05</span>Substance Use Navigation</a></li>
 <li><a href="#multidisciplinary-care"><span class="section-num">06</span>Multidisciplinary Care Coordination</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In Module 16, we've been delving into complex cases, from neurodivergence to chronic pain and relactation. This lesson builds on your advanced clinical problem-solving by equipping you to navigate the intricate landscape of maternal medications and substance use. You'll learn how to apply the <span class="highlight">L.A.T.C.H. Support Method‚Ñ¢</span> to ensure both maternal and infant safety and well-being in these sensitive scenarios.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Confident Coach!</h3>
 <p>As a Certified Breastfeeding Support Coach, you will inevitably encounter clients who are taking medications or navigating past or present substance use. This can be a source of significant anxiety for parents, who often receive conflicting advice or feel judged. Your role is crucial: to provide <span class="highlight">evidence-based information, compassionate support, and clear pathways for coordinated care</span>. This lesson will empower you to confidently screen for medication risks, troubleshoot common challenges, and support clients with empathy and professionalism, ensuring the safest and most informed feeding decisions for their families.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Utilize evidence-based resources like Hale‚Äôs and LactMed for accurate medication risk assessment during lactation.</li>
 <li>Formulate support strategies for clients breastfeeding while on psychotropic, immunosuppressant, or chronic pain medications.</li>
 <li>Implement communication techniques to reduce maternal anxiety regarding potential medication transfer into breast milk.</li>
 <li>Analyze complex case scenarios, such as breastfeeding during chemotherapy, to guide informed decision-making.</li>
 <li>Apply harm reduction principles and facilitate referrals for clients navigating substance use challenges.</li>
 <li>Advocate for and facilitate multidisciplinary care coordination for clients with medication or substance use needs.</li>
 </ul>
 </div>

 <!-- Main Content -->
 <h2 id="medication-screening">01. Listen & Learn: Evidence-Based Medication Screening</h2>
 <p>One of the most common questions breastfeeding parents have is about the safety of medications. Your first step, aligning with the <span class="highlight">Listen & Learn</span> component of the L.A.T.C.H. method, is to gather thorough information and then consult reliable, evidence-based resources. It's vital to remember that coaches do not prescribe or de-prescribe medications, but we can provide accurate information to empower clients and their healthcare providers.</p>

 <h3>Key Resources: Hale's and LactMed</h3>
 <p>These two resources are considered the gold standard for evaluating medication safety during lactation:</p>
 <ul>
 <li><strong>Hale's Medications & Mothers' Milk:</strong> Authored by Dr. Thomas Hale, this comprehensive textbook (updated biennially) provides detailed information on hundreds of medications. Each drug is assigned a <span class="highlight">Lactation Risk Category (LRC)</span> from L1 (safest) to L5 (contraindicated). It offers data on maternal absorption, infant exposure, potential side effects, and alternative medications.</li>
 <li><strong>LactMed (Drugs and Lactation Database):</strong> A free, online database maintained by the National Library of Medicine (NIH). LactMed is continuously updated and provides concise, evidence-based information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes drug levels in milk and infant blood, possible adverse effects in infants, and alternative drugs.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Navigating Conflicting Information:</strong> Many clients will have received outdated or overly cautious advice from healthcare providers unfamiliar with modern lactation pharmacology. Empower them by saying: "It's understandable to feel confused. Medical knowledge evolves quickly! We're fortunate to have specialized resources like Hale's and LactMed that consolidate the latest research on medications and breastfeeding. Let's look at what the experts say about your specific medication together, and then you can share this information with your doctor to have a fully informed discussion."</p>
 </div>

 <h3>Interpreting Medication Data</h3>
 <p>When using these resources, focus on key metrics:</p>
 <ul>
 <li><strong>Relative Infant Dose (RID):</strong> This is the most crucial metric, representing the estimated infant drug dose via milk as a percentage of the maternal dose (adjusted for weight). An RID <span class="stat-highlight">below 10%</span> is generally considered safe for most medications, though lower is always preferred.</li>
 <li><strong>Infant Monitoring Parameters:</strong> What specific signs or symptoms should the parent look for in the infant (e.g., drowsiness, poor feeding, irritability)?</li>
 <li><strong>Timing of Doses:</strong> Some medications have a short half-life, allowing for strategic timing of doses (e.g., immediately after a feeding) to minimize infant exposure.</li>
 <li><strong>Infant Age and Health:</strong> Preterm, critically ill, or neonates are generally more vulnerable to drug exposure due to immature metabolic systems.</li>
 </ul>

 <h2 id="high-risk-medications">02. Troubleshoot & Target: Common High-Risk Medications</h2>
 <p>The <span class="highlight">Troubleshoot & Target</span> phase involves understanding the nuances of specific medication categories that often raise concerns. While comprehensive knowledge requires ongoing study, understanding general principles for common classes is essential.</p>

 <h3>Psychotropic Medications (SSRIs, SNRIs, Mood Stabilizers)</h3>
 <p>Postpartum mood and anxiety disorders affect a significant number of parents, with <span class="stat-highlight">up to 1 in 7 mothers</span> experiencing postpartum depression (PPD) (Ko et al., 2023). Many may require psychotropic medications.</p>
 <ul>
 <li><strong>SSRIs (Selective Serotonin Reuptake Inhibitors):</strong> Generally considered compatible with breastfeeding. Sertraline (Zoloft) and Paroxetine (Paxil) are often preferred due to low infant exposure. Fluoxetine (Prozac) and Citalopram (Celexa) have slightly higher RIDs but are often used successfully.</li>
 <li><strong>SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors):</strong> Venlafaxine (Effexor) and Desvenlafaxine (Pristiq) are often compatible but require careful monitoring.</li>
 <li><strong>Mood Stabilizers & Antipsychotics:</strong> Lithium is generally discouraged due to high infant exposure. Other medications like Quetiapine (Seroquel) or Olanzapine (Zyprexa) may be used with close infant monitoring.</li>
 </ul>
 <p><strong>Coaching Focus:</strong> Emphasize the importance of maternal mental health. An untreated mood disorder poses a greater risk to both mother and infant than minimal medication exposure. Encourage timing doses, observing for infant sedation/irritability, and consistent communication with the prescribing provider.</p>

 <h3>Immunosuppressants and Biologic Therapies</h3>
 <p>For clients with autoimmune conditions (e.g., Crohn's disease, rheumatoid arthritis, lupus), immunosuppressants or biologics may be necessary. Many of these medications, especially large protein molecules like biologics, have minimal transfer into breast milk due to their size or are rapidly degraded in the infant's gut.</p>
 <ul>
 <li><strong>TNF-alpha Inhibitors (e.g., Adalimumab, Infliximab):</strong> Generally considered compatible. Infant exposure is very low.</li>
 <li><strong>Corticosteroids (e.g., Prednisone):</strong> High doses may warrant waiting 4 hours after a dose before breastfeeding, but lower doses are generally compatible.</li>
 </ul>
 <p><strong>Coaching Focus:</strong> These cases require careful collaboration with the client's specialist. Help the client understand that "minimal transfer" can be very reassuring and empower them to discuss this with their rheumatologist or gastroenterologist, armed with the latest data.</p>

 <h3>Chronic Pain Medications</h3>
 <p>Chronic pain can significantly impact a parent's ability to care for their infant and maintain lactation. Options range from NSAIDs to opioids.</p>
 <ul>
 <li><strong>NSAIDs (e.g., Ibuprofen, Naproxen):</strong> Generally considered safe for short-term use. Ibuprofen is an L1 (safest) medication.</li>
 <li><strong>Opioids (e.g., Oxycodone, Hydrocodone, Morphine):</strong> Use with extreme caution. Short-term, low-dose use of specific opioids (e.g., codeine, tramadol) can be acceptable, but <span class="highlight">infant sedation and respiratory depression are significant risks</span>. The parent must be educated on signs of infant sedation. Avoid if possible.</li>
 <li><strong>Neuropathic Pain Medications (e.g., Gabapentin, Pregabalin):</strong> Generally considered compatible with monitoring for infant sedation.</li>
 </ul>
 <p><strong>Coaching Focus:</strong> Prioritize pain management while minimizing infant risk. Explore non-pharmacological pain relief (e.g., heat/cold, massage, physical therapy) and help the client discuss safer alternatives or dose timing with their provider. Never recommend stopping a prescribed opioid without medical consultation.</p>

 <div class="data-table-container">
 <h3>Medication Compatibility Overview (General Guidelines)</h3>
 <table class="data-table">
 <thead>
 <tr>
 <th>Medication Class</th>
 <th>General Compatibility</th>
 <th>Key Considerations for Coaching</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>SSRIs (e.g., Sertraline, Paroxetine)</strong></td>
 <td>Generally compatible (L1-L2)</td>
 <td>Prioritize maternal mental health. Monitor infant for drowsiness/irritability.</td>
 </tr>
 <tr>
 <td><strong>NSAIDs (e.g., Ibuprofen, Naproxen)</strong></td>
 <td>Generally compatible (L1-L2)</td>
 <td>Short-term use preferred. Ibuprofen is a top choice.</td>
 </tr>
 <tr>
 <td><strong>Antihistamines (non-sedating)</strong></td>
 <td>Generally compatible (L1-L2)</td>
 <td>Sedating antihistamines (e.g., Diphenhydramine) can cause infant drowsiness.</td>
 </tr>
 <tr>
 <td><strong>Antibiotics (most common)</strong></td>
 <td>Many are compatible (L1-L2)</td>
 <td>Check specific drug. Watch for infant GI upset (diarrhea, thrush).</td>
 </tr>
 <tr>
 <td><strong>Immunosuppressants/Biologics</strong></td>
 <td>Often compatible (L2-L3)</td>
 <td>Large molecules, low transfer. Coordinate with specialists.</td>
 </tr>
 <tr>
 <td><strong>Opioids (e.g., Oxycodone, Morphine)</strong></td>
 <td>Use with extreme caution (L3-L4)</td>
 <td>Significant risk of infant sedation. Monitor closely. Avoid if possible.</td>
 </tr>
 <tr>
 <td><strong>Chemotherapy Agents</strong></td>
 <td>Generally contraindicated (L5)</td>
 <td>Cessation of breastfeeding usually recommended. Explore milk banking options.</td>
 </tr>
 </tbody>
 </table>
 </div>

 <h2 id="maternal-anxiety">03. Comfort & Connection: Reducing Maternal Anxiety Regarding 'Tainted' Milk</h2>
 <p>Many parents express profound guilt or fear that their milk is "tainted" or harmful to their baby due to medication. This fear can undermine their confidence and lead to premature cessation of breastfeeding. Your role in <span class="highlight">Comfort & Connection</span> is to provide empathetic, non-judgmental support and accurate information.</p>
 <ul>
 <li><strong>Normalize Concerns:</strong> Acknowledge their worries. "It's completely natural to be concerned about anything that might affect your baby. You're a wonderful parent for thinking about this."</li>
 <li><strong>Provide Context:</strong> Explain that most medications transfer into breast milk in very small amounts, often far below therapeutic doses for the infant. The RID helps quantify this.</li>
 <li><strong>Emphasize Benefits:</strong> Remind them of the immense benefits of breast milk, which often outweigh the minimal risks of compatible medications. For example, a mother with well-managed PPD is better able to bond and care for her infant than one struggling without treatment.</li>
 <li><strong>Focus on Observation:</strong> Empower parents to be vigilant observers of their infant. What are the specific signs to watch for? (e.g., unusual drowsiness, poor feeding, changes in stool).</li>
 <li><strong>Support Shared Decision-Making:</strong> Encourage open dialogue between the parent and their healthcare team. Provide them with the resources (Hale's, LactMed) to facilitate these discussions.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Empowering the "Detective":</strong> When a client expresses fear, say, "Let's put on our detective hats together. We'll consult the best resources, understand the actual science, and gather all the facts. Your concerns are valid, and by getting clear information, you'll feel much more confident in making the best decision for you and your baby." This reframes anxiety into proactive problem-solving.</p>
 </div>

 <h2 id="chemotherapy-case">04. Case Study: Navigating Breastfeeding During Maternal Chemotherapy</h2>
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Complex Case Study</p>
 <p class="subtitle">Amelia's Chemotherapy Journey</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Client:</strong> Amelia, 45-year-old mother of a 3-month-old infant</p>
 <p><strong>Presenting Situation:</strong> Diagnosed with Stage II breast cancer, requiring chemotherapy. She is exclusively breastfeeding and devastated by the prospect of stopping.</p>
 <p><strong>Medical History:</strong> Healthy pregnancy, uncomplicated birth. No prior history of chronic illness or medication use. Infant is thriving, exclusively breastfed since birth.</p>
 <p><strong>Emotional State:</strong> High anxiety, grief over diagnosis, fear of harming her infant, strong desire to continue breastfeeding for its health benefits and emotional comfort.</p>
 </div>
 <p><strong>Coaching Intervention & Outcomes:</strong></p>
 <ol>
 <li><strong>Listen & Learn:</strong> Amelia expressed immense guilt and sadness. Our initial sessions focused on active listening, validating her grief and fears, and normalizing her strong desire to protect her infant. We established that her priority was her health and her baby's safety.</li>
 <li><strong>Medication Assessment:</strong> We reviewed her specific chemotherapy regimen (e.g., Doxorubicin, Cyclophosphamide). Using Hale's and LactMed, we confirmed that most chemotherapy agents are <span class="highlight">contraindicated (L5)</span> during breastfeeding due to their high toxicity and potential for severe adverse effects on the infant (e.g., bone marrow suppression, organ damage).</li>
 <li><strong>Education & Options:</strong>
 <ul>
 <li>We gently explained the significant risks of chemotherapy agents passing into breast milk and reiterated the consensus among lactation pharmacology experts that breastfeeding is generally not recommended during active chemotherapy (Anderson & Hale, 2021).</li>
 <li>We discussed options for maintaining her milk supply if she wished to relactate later (e.g., pumping to maintain supply and "pump and dump" if desired, though this isn't always necessary if milk is not given to the infant).</li>
 <li>We explored the option of using banked donor milk or formula as safe feeding alternatives during treatment.</li>
 </ul>
 </li>
 <li><strong>Emotional Support & Connection:</strong> We focused on grieving the loss of her breastfeeding journey as she envisioned it. We emphasized that her love and connection with her baby were paramount, regardless of how her baby was fed. We explored other ways to maintain closeness, such as skin-to-skin contact, babywearing, and feeding with donor milk/formula while holding her baby close.</li>
 <li><strong>Multidisciplinary Coordination:</strong> We encouraged Amelia to have an open conversation with her oncologist, armed with the information we discussed. We offered to help her formulate questions for her medical team regarding treatment safety, timing, and future lactation possibilities.</li>
 </ol>
 <p class="case-context"><strong>Outcome:</strong> Amelia chose to temporarily cease breastfeeding during her active chemotherapy. She expressed and stored some milk for future use (after chemotherapy completion, if deemed safe by her medical team), and transitioned her infant to donor milk and formula. She found immense comfort in continuing skin-to-skin contact and felt empowered by the knowledge that she was making the safest decision for her baby, despite her profound sadness. Her focus shifted from "tainted milk" to "prioritizing health and connection."</p>
 </div>
 </div>

 <h2 id="substance-use">05. Substance Use Navigation</h2>
 <p>Supporting clients with current or past substance use is a delicate and critical aspect of advanced lactation support. It requires a <span class="highlight">harm reduction approach</span>, non-judgmental communication, and clear pathways for referral.</p>
 <ul>
 <li><strong>Harm Reduction Philosophy:</strong> The goal is to minimize negative health and social consequences associated with substance use. This means working with the client where they are, acknowledging their challenges, and supporting any steps they take towards safer practices, even if complete abstinence isn't immediately achievable.</li>
 <li><strong>Common Substances & General Guidance:</strong>
 <ul>
 <li><strong>Alcohol:</strong> Moderate consumption (1-2 drinks) is generally compatible if timed to allow for clearance from milk (typically 2-3 hours per drink). Heavy, chronic use is contraindicated.</li>
 <li><strong>Cannabis (Marijuana):</strong> While often perceived as natural, THC does transfer into breast milk and can accumulate. Potential long-term effects on infant neurodevelopment are still being studied, but caution is advised. Most experts recommend avoiding cannabis during lactation (Goyal et al., 2017).</li>
 <li><strong>Nicotine (Smoking/Vaping):</strong> While not a contraindication, nicotine and its metabolites transfer into milk. Smoking also increases SIDS risk. Encouraging cessation or reduction is key, but if a parent continues, breastfeeding is still preferred over formula feeding due to the overall benefits.</li>
 <li><strong>Opioids (Illicit/Misused Prescriptions):</strong> High risk of infant sedation and respiratory depression. Breastfeeding is generally contraindicated. Urgent referral to addiction specialists is paramount.</li>
 </ul>
 </li>
 <li><strong>Non-Judgmental Support:</strong> Clients struggling with substance use often face immense stigma. Your role is to create a safe space for them to disclose, seek help, and make informed decisions without fear of judgment or punitive action.</li>
 <li><strong>Referral Pathways:</strong> Always be prepared to refer clients to addiction specialists, mental health professionals, social workers, and local support groups. Your role is not to treat addiction but to support the lactation journey within a comprehensive care plan.</li>
 </ul>

 <h2 id="multidisciplinary-care">06. Holistic Habits: Coordinating Care with Multidisciplinary Medical Teams</h2>
 <p>Effective management of clients on medications or navigating substance use requires a truly <span class="highlight">Holistic Habits</span> approach, emphasizing seamless communication and collaboration with other healthcare providers. No single professional has all the answers, and a team approach yields the best outcomes.</p>
 <ul>
 <li><strong>Identify Key Players:</strong> Who is on the client's medical team? (e.g., OB/GYN, pediatrician, family doctor, psychiatrist, rheumatologist, oncologist, pharmacist, addiction specialist).</li>
 <li><strong>Facilitate Communication:</strong> Encourage your client to share information between providers. Offer to help them formulate questions or even provide relevant peer-reviewed articles (e.g., from LactMed) to their doctor. With the client's explicit consent, you may be able to communicate directly with other members of their care team.</li>
 <li><strong>Documentation:</strong> Maintain meticulous records of your consultations, recommendations, and referrals. Document any information you provide from Hale's or LactMed, and always note that medical decisions are made by the client in consultation with their prescribing physician.</li>
 <li><strong>Advocacy:</strong> Be an advocate for the breastfeeding dyad. Many providers, while well-meaning, may lack current knowledge on lactation pharmacology. Your informed support can empower clients to seek second opinions or clearer guidance.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Building Your Referral Network:</strong> Proactively identify local resources: mental health therapists specializing in perinatal mood disorders, addiction counselors, and pharmacies with pharmacists knowledgeable in lactation pharmacology. Having these contacts ready will allow you to provide seamless support and avoid delays in critical care for your clients.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">1</span>
 <p class="question-text">A client is taking a medication for an autoimmune condition and is concerned about its safety while breastfeeding. Which two primary evidence-based resources should you consult for information?</p>
 </div>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">The two primary resources are <strong>Hale's Medications & Mothers' Milk</strong> and <strong>LactMed (Drugs and Lactation Database)</strong>. These provide comprehensive, evidence-based data on medication compatibility with breastfeeding.</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">2</span>
 <p class="question-text">What is the significance of the "Relative Infant Dose (RID)" when assessing medication safety during lactation?</p>
 </div>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">The <strong>Relative Infant Dose (RID)</strong> is a crucial metric that estimates the infant's drug exposure via breast milk as a percentage of the maternal dose (adjusted for weight). An RID <span class="highlight">below 10%</span> is generally considered safe for most medications, indicating low infant exposure.</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">3</span>
 <p class="question-text">A client expresses guilt and fear, believing her breast milk is "tainted" because she needs to take an antidepressant. How would you apply the "Comfort & Connection" aspect of the L.A.T.C.H. method to support her?</p>
 </div>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">To apply "Comfort & Connection," I would first <strong>normalize her concerns</strong>, validating her feelings without judgment. I would then <strong>provide context</strong> by explaining that most medications transfer in very small amounts and emphasize the immense benefits of breast milk, often outweighing minimal risks. I would also focus on her mental well-being, reiterating that a healthy, supported mother is best for the baby, and encourage open dialogue with her medical team.</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">4</span>
 <p class="question-text">When supporting a client who is navigating substance use (e.g., cannabis or alcohol), what is the foundational principle you should adopt, and what is your role as a coach?</p>
 </div>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">The foundational principle is a <strong>harm reduction approach</strong>, focusing on minimizing negative health consequences associated with substance use. As a coach, your role is to provide <strong>non-judgmental support</strong>, educate the client on evidence-based risks, and facilitate <strong>referrals to addiction specialists</strong> and other relevant healthcare providers. You do not treat addiction but support the client's lactation journey within a comprehensive care plan.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Utilize <strong>Hale's Medications & Mothers' Milk</strong> and <strong>LactMed</strong> as your primary, evidence-based resources for assessing medication safety during lactation.</li>
 <li>Understand the <strong>Relative Infant Dose (RID)</strong> as a crucial metric, with <span class="highlight">RID &lt; 10%</span> generally indicating low risk for most medications.</li>
 <li>Provide empathetic and non-judgmental support to parents concerned about medication exposure, emphasizing the benefits of breastfeeding and the importance of maternal well-being.</li>
 <li>Approach substance use with a <strong>harm reduction philosophy</strong>, offering support, education, and appropriate referrals to specialized care.</li>
 <li>Prioritize and actively facilitate <strong>multidisciplinary care coordination</strong>, ensuring open communication between the client and all members of their healthcare team.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Anderson, P. O., & Hale, T. W. (2021). <em>Hale's Medications & Mothers' Milk 2021</em> (19th ed.). Springer Publishing Company.</li>
 <li>Drugs and Lactation Database (LactMed). (2023). National Library of Medicine (US). Retrieved from <a href="https://www.ncbi.nlm.nih.gov/books/NBK507908/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK507908/</a></li>
 <li>Goyal, N. K., et al. (2017). "Marijuana and Breastfeeding." <em>Pediatrics, 140</em>(3), e20170428.</li>
 <li>Ko, J. Y., et al. (2023). "Trends in Postpartum Depressive Symptoms ‚Äî 27 States, 2018 and 2020." <em>Morbidity and Mortality Weekly Report, 72</em>(19), 509‚Äì515.</li>
 <li>Lawrence, R. M., & Lawrence, R. A. (2022). <em>Breastfeeding: A Guide for the Medical Profession</em> (9th ed.). Elsevier.</li>
 <li>National Institute on Drug Abuse (NIDA). (2023). <em>Substance Use in Women: Breastfeeding.</em> Retrieved from <a href="https://www.drugabuse.gov/publications/drugfacts/substance-use-women-breastfeeding" target="_blank">https://www.drugabuse.gov/publications/drugfacts/substance-use-women-breastfeeding</a></li>
 <li>Pati, S., et al. (2021). "The safety of psychotropic medications during breastfeeding: A systematic review." <em>Journal of Clinical Psychopharmacology, 41</em>(4), 406-419.</li>
 </ol>
 </div>

</div> <!-- /lesson-wrapper -->

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>
</body>
</html>